| scholarly article | Q13442814 |
| P50 | author | Charis Eng | Q37385393 |
| P2093 | author name string | Petra Platzer | |
| Marcus G Pezzolesi | |||
| Kristin A Waite | |||
| P2860 | cites work | The lipid phosphatase activity of PTEN is critical for its tumor supressor function | Q22007981 |
| Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway | Q24532136 | ||
| Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia | Q24539231 | ||
| MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias | Q24564008 | ||
| Protean PTEN: form and function | Q24613810 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Prediction of mammalian microRNA targets | Q27860498 | ||
| MicroRNA gene expression deregulation in human breast cancer | Q27860690 | ||
| PTEN: one gene, many syndromes | Q28203387 | ||
| Reduced accumulation of specific microRNAs in colorectal neoplasia | Q28211976 | ||
| High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma | Q28236173 | ||
| MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells | Q28262214 | ||
| Cancer phenomics: RET and PTEN as illustrative models | Q28278854 | ||
| Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN | Q28513537 | ||
| Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines | Q28975767 | ||
| MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer | Q29547523 | ||
| Regulation of PTEN phosphorylation and stability by a tumor suppressor candidate protein. | Q29977747 | ||
| PTEN: a tumour suppressor that functions as a phospholipid phosphatase | Q33594251 | ||
| PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome | Q34504165 | ||
| Distinct expression profiles for PTEN transcript and its splice variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome. | Q34658356 | ||
| Cowden syndrome-affected patients with PTEN promoter mutations demonstrate abnormal protein translation | Q36430799 | ||
| Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein | Q36718966 | ||
| Comparative genomic and functional analyses reveal a novel cis-acting PTEN regulatory element as a highly conserved functional E-box motif deleted in Cowden syndrome | Q38304010 | ||
| Nuclear localization of PTEN is regulated by Ca(2+) through a tyrosil phosphorylation-independent conformational modification in major vault protein | Q40192972 | ||
| BMP2 exposure results in decreased PTEN protein degradation and increased PTEN levels | Q44350476 | ||
| Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation | Q45345194 | ||
| Genetic background controls tumor development in PTEN-deficient mice. | Q46241404 | ||
| Germline mutations in PTEN are present in Bannayan-Zonana syndrome | Q48046915 | ||
| Early loss of heterozygosity on 17q in ovarian cancer. The Abe Ovarian Cancer Genetics Group. | Q53487142 | ||
| Localization of the gene for Cowden disease to chromosome 10q22–23 | Q57694734 | ||
| PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death | Q73229813 | ||
| Loss of heterozygosity at chromosome 13q in hepatocellular carcinoma: identification of three independent regions | Q73446756 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | 1141-1149 | |
| P577 | publication date | 2008-05-01 | |
| P1433 | published in | American Journal of Human Genetics | Q4744249 |
| P1476 | title | Differential expression of PTEN-targeting microRNAs miR-19a and miR-21 in Cowden syndrome | |
| P478 | volume | 82 |
| Q53079070 | AKT kinase pathway: a leading target in cancer research. |
| Q36968033 | ANT2 shRNA downregulates miR-19a and miR-96 through the PI3K/Akt pathway and suppresses tumor growth in hepatocellular carcinoma cells |
| Q33740171 | Allele-specific tumor spectrum in pten knockin mice |
| Q54295055 | Altered expression of microRNA miR-21, miR-155, and let-7a and their roles in pulmonary neuroendocrine tumors. |
| Q33756981 | Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer |
| Q35871493 | Apoptosis and the target genes of microRNA-21. |
| Q39418655 | Ars2 is overexpressed in human cholangiocarcinomas and its depletion increases PTEN and PDCD4 by decreasing microRNA-21. |
| Q36847305 | Cowden syndrome-related mutations in PTEN associate with enhanced proteasome activity |
| Q35218751 | Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers |
| Q35999401 | EMT and induction of miR-21 mediate metastasis development in Trp53-deficient tumours |
| Q36534187 | Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers |
| Q34523189 | Elevation of methylated DNA in KILLIN/PTEN in the plasma of patients with thyroid and/or breast cancer |
| Q39514896 | Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer |
| Q33781314 | Exosome miR-371b-5p promotes proliferation of lung alveolar progenitor type II cells by using PTEN to orchestrate the PI3K/Akt signaling |
| Q44943436 | Expression and prognostic value of Ars2 in hepatocellular carcinoma |
| Q34115364 | HIV-1 Nef and KSHV oncogene K1 synergistically promote angiogenesis by inducing cellular miR-718 to regulate the PTEN/AKT/mTOR signaling pathway |
| Q24569637 | High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients |
| Q38497311 | Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation. |
| Q34354739 | In-depth profiling and analysis of host and viral microRNAs in Japanese flounder (Paralichthys olivaceus) infected with megalocytivirus reveal involvement of microRNAs in host-virus interaction in teleost fish |
| Q34030947 | Increased prevalence of eosinophilic gastrointestinal disorders in pediatric PTEN hamartoma tumor syndromes |
| Q30418688 | MiR-21/Smad 7 signaling determines TGF-β1-induced CAF formation |
| Q37981156 | MicroRNA Control of Invasion and Metastasis Pathways |
| Q24644251 | MicroRNA let-7: an emerging next-generation cancer therapeutic |
| Q37930520 | MicroRNA-21: a ubiquitously expressed pro-survival factor in cancer and other diseases |
| Q36304803 | MicroRNA-26b Modulates the NF-κB Pathway in Alveolar Macrophages by Regulating PTEN. |
| Q89475347 | MicroRNA-498 promotes proliferation and migration by targeting the tumor suppressor PTEN in breast cancer cells |
| Q39653380 | MicroRNA-dependent regulation of PTEN after arsenic trioxide treatment in bladder cancer cell line T24. |
| Q36134682 | MicroRNAs in thyroid cancer |
| Q36908289 | Myocardial AKT: the omnipresent nexus |
| Q37453183 | Network analysis of human post-mortem microarrays reveals novel genes, microRNAs, and mechanistic scenarios of potential importance in fighting huntington's disease |
| Q52686168 | Network of MicroRNAs Mediate Translational Repression of Bone Morphogenetic Protein Receptor-2: Involvement in HIV-Associated Pulmonary Vascular Remodeling. |
| Q36218182 | Oncogenic microRNA 17-92 cluster is regulated by epithelial cell adhesion molecule and could be a potential therapeutic target in retinoblastoma |
| Q42011584 | PI3K/AKT/PTEN Signaling as a Molecular Target in Leukemia Angiogenesis |
| Q28383083 | PI3K/PTEN signaling in angiogenesis and tumorigenesis |
| Q38280809 | PTEN hamartoma tumor syndrome: clinical risk assessment and management protocol |
| Q42412809 | PTEN in liver diseases and cancer |
| Q35087819 | Plasma microRNAs as potential biomarkers for non-small-cell lung cancer |
| Q64089233 | Polymeric Co-Delivery Systems in Cancer Treatment: An Overview on Component Drugs' Dosage Ratio Effect |
| Q43803974 | Role of miR-19a targeting TNF-α in mediating ulcerative colitis |
| Q39628381 | Role of microRNA-21 and effect on PTEN in Kazakh's esophageal squamous cell carcinoma |
| Q42527577 | Roles of PI3K/AKT/GSK3/mTOR Pathway in Cell Signaling of Mental Illnesses |
| Q83381970 | Stromal miR-320 keeps an oncogenic secretome in check |
| Q35682218 | Structural effects of linkage disequilibrium on the transcriptome |
| Q37506648 | The PTEN-AKT3 signaling cascade as a therapeutic target in melanoma |
| Q24657924 | The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo |
| Q45901790 | The microRNA-21/PTEN pathway regulates the sensitivity of HER2-positive gastric cancer cells to trastuzumab. |
| Q37995125 | Thyroid disease associated with Cowden syndrome: A meta-analysis |
| Q60915309 | Total Flavonoids from Sarg. Leaves Alleviate H9c2 Cells Hypoxia/Reoxygenation Injury via Effects on miR-21 Expression, PTEN/Akt, and the Bcl-2/Bax Pathway |
| Q34998307 | Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer |
| Q37204184 | miR-19a/b modulates lung cancer cells metastasis through suppression of MXD1 expression |
| Q92354556 | miR-21: a promising biomarker for the early detection of colon cancer |
Search more.